CASPER MARC N sold $12.6M of TMO

CASPER MARC N (Chairman & CEO) sold 20,000 shares of THERMO FISHER SCIENTIFIC INC. (TMO) at an average of $628.09 ($625.45–$633.99, $12.56M total) across 14 trades over 2026-08-20 to 2026-08-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · CASPER MARC N
Published Aug 24, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TMO
Neutral
medium confidence
Mentioned
$TMO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TMONeutralLow
01

Why it matters

The CEO's sale reduces his ownership but does not alter company fundamentals; market reaction is likely muted.

02

Market read

Primary insider sale; modest size; limited trading relevance.

03

What to watch

The 10b5‑1 plan pre‑arranges sales, reducing the informational value of the timing.

Relevance 6/10Novelty 7/10Timing: post‑market filing

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$TMONeutralMedium confidence
Context

CEO Casper Marc N sold 20,000 shares for $12.6M via a 10b5‑1 plan, reducing his stake to 123,925 shares.

Expected impact

Potential short‑term downward pressure of 0.5‑1% if market interprets negatively.

Evidence & confidence

The transaction is a primary disclosure (Form 4) and sizable enough to be noted, yet it represents only ~0.04% of outstanding shares.

Market effects

Minimal impact on the life‑sciences equipment sector; other peers unlikely to be affected.

U.S. market only; no broader regional effect.

Limited to investors tracking Thermo Fisher insider activity.

Counterpoint

The sale could be a routine diversification rather than a negative signal, so traders might ignore it.

Key entities

  • Thermo Fisher Scientific Inc.

    Global provider of scientific instruments and services.

  • Casper Marc N

    Chairman & CEO of Thermo Fisher Scientific.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TMOMed

Thermo Fisher Scientific Replenishes Buyback Capacity to $5 Billion

Thermo Fisher Scientific (TMO) authorized up to $5B in new stock repurchases, replacing a prior authorization with $1B remaining. The company spent $4B on buybacks in 2026's first nine months, with no purchases in Q3. Operating cash flow increased to $5.867B for the period, with $4.618B in free cash flow. The new authorization complements acquisitions, dividends, and debt obligations.